Cofoe Medical Technology Co.,Ltd. (SHE:301087)

Cofoe Medical Technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,772	2,842	2,706	2,869	2,129	2,324
Other Revenue	141.38	141.38	148.02	108.05	146.74	51.66
Revenue	2,914	2,983	2,854	2,977	2,276	2,375
Revenue Growth (YoY)	3.85%	4.53%	-4.14%	30.82%	-4.19%	62.46%
Cost of Revenue	1,416	1,468	1,670	1,839	1,296	1,376
Gross Profit	1,498	1,515	1,184	1,137	979.57	999.13
Selling, General & Admin	1,116	1,095	851.63	740.79	471.08	483.56
Research & Development	92.88	96.41	114.33	118.42	70.59	43.11
Other Operating Expenses	-0.47	8.88	8.18	12.65	6.24	-0.36
Operating Expenses	1,212	1,205	973.55	886.23	558.69	529.48
Operating Income	285.22	309.73	210.31	251.23	420.89	469.65
Interest Expense	-18.06	-17.91	-13.5	-10.85	-6.81	-1.44
Interest & Investment Income	61.41	54.71	82.02	102.64	14.41	8.3
Earnings From Equity Investments	-	-	-	-	-	-1.43
Currency Exchange Gain (Loss)	0.52	0.52	0.16	0.36	-0.19	-0.1
Other Non Operating Income (Expenses)	-1.68	-1.9	-3.27	-2.49	-0.44	-2.06
EBT Excluding Unusual Items	327.41	345.15	275.71	340.89	427.86	472.91
Impairment of Goodwill	-	-	-	-0.15	-	-
Gain (Loss) on Sale of Investments	9.58	9.4	-1.56	4.4	6.02	-
Gain (Loss) on Sale of Assets	5.9	5.88	4.59	6.47	0.14	0.22
Asset Writedown	-5.44	-2.32	-2.24	-35.14	-0.05	-0.01
Legal Settlements	2.19	2.19	-2.41	-	-0.16	-
Other Unusual Items	23.04	11.69	11.61	17.91	74.51	26.9
Pretax Income	362.68	372	285.71	334.39	508.33	500.02
Income Tax Expense	59.81	59.66	32.84	32.37	78.74	75.48
Earnings From Continuing Operations	302.88	312.34	252.87	302.02	429.59	424.54
Minority Interest in Earnings	-0.92	-0.59	1.41	-0.34	-0.73	-0.59
Net Income	301.95	311.75	254.28	301.68	428.86	423.95
Net Income to Common	301.95	311.75	254.28	301.68	428.86	423.95
Net Income Growth	36.64%	22.60%	-15.71%	-29.65%	1.16%	242.76%
Shares Outstanding (Basic)	204	204	205	208	165	156
Shares Outstanding (Diluted)	205	206	205	208	165	156
Shares Change (YoY)	0.09%	0.46%	-1.70%	26.56%	5.47%	0.08%
EPS (Basic)	1.48	1.53	1.24	1.45	2.60	2.72
EPS (Diluted)	1.47	1.51	1.24	1.45	2.60	2.72
EPS Growth	36.23%	21.77%	-14.48%	-44.23%	-4.25%	242.51%
Free Cash Flow	389.22	542.9	20.6	-540.87	-273.25	122.2
Free Cash Flow Per Share	1.90	2.64	0.10	-2.60	-1.66	0.78
Dividend Per Share	1.800	1.800	1.200	1.200	1.231	-
Dividend Growth	50.00%	50.00%	-	-2.50%	-	-
Gross Margin	51.40%	50.79%	41.48%	38.21%	43.05%	42.06%
Operating Margin	9.79%	10.38%	7.37%	8.44%	18.50%	19.77%
Profit Margin	10.36%	10.45%	8.91%	10.13%	18.85%	17.85%
Free Cash Flow Margin	13.36%	18.20%	0.72%	-18.17%	-12.01%	5.15%
EBITDA	391.27	411.31	293.98	292.34	449.78	486.09
EBITDA Margin	13.43%	13.79%	10.30%	9.82%	19.77%	20.46%
D&A For EBITDA	106.06	101.58	83.67	41.11	28.89	16.44
EBIT	285.22	309.73	210.31	251.23	420.89	469.65
EBIT Margin	9.79%	10.38%	7.37%	8.44%	18.50%	19.77%
Effective Tax Rate	16.49%	16.04%	11.49%	9.68%	15.49%	15.10%
Revenue as Reported	2,914	2,983	2,854	2,977	2,276	2,375
Advertising Expenses	-	225.57	206.59	151.96	86.71	97.51

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.